Dudediligence.

Champions Oncology, Inc

CSBRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$13.5MOct ’24$17.0MJan ’25$12.4MApr ’25$14.0MJul ’25$15.0MOct ’25$16.6MJan ’26$13.8MApr ’26$15.2MJul ’26
Net income, by quarter
$728,000Oct ’24$4.5MJan ’25−$1.8MApr ’25−$436,000Jul ’25$268,000Oct ’25−$279,000Jan ’26$506,825Apr ’26−$426,000Jul ’26
Fiscal years, by the month each ended
LineApr 2022Apr 2023Apr 2024Apr 2025Apr 2026
Revenue$49.1M$53.9M$50.2M$56.9M$59.4M
Gross profit$25.5M$24.3M$20.8M$28.6M$28.5M
Operating income$607,000−$5.3M−$7.4M$4.6M−$1.1M
Net income$548,000−$5.3M−$7.3M$4.7M−$1,175
Operating cash flow$6.5M$4.0M−$6.1M$7.4M−$4.5M
Free cash flow$4.1M$1.1M−$7.0M$7.0M−$5.0M
Cash$9.0M$10.1M$2.6M$9.8M$4.9M
Shares outstanding13.5M13.5M13.6M13.8M13.9M